D. JEWELL

Genome-wide association defines more than 30 distinct susceptibility loci for Crohn's disease (2008)

BARRETT, JC, HANSOUL, S, NICOLAE, DL, CHO, JH, DUERR, RH, RIOUX, JD, ...

IOIBD questionnaire on the clinical use of azathioprine, 6-mercaptopurine, cyclosporin A and methotrexate in the treatment of inflammatory bowel diseases (2000)

Ewe, K, Gassull, M A, Geboes, K, Jewell, D, Pallone, F, ...

OBJECTIVE: To obtain information on the clinical experience with azathioprine (AZA), 6-mercaptopurine (6-MP), cyclosporin A (CyA) and methotrexate (MTX) in the treatment of patients with inflammatory...

Exclusion of linkage of Crohn's disease to previously reported regions on chromosomes 12, 7, and 3 in the Belgian population indicates genetic heterogeneity. (2000)

VERMEIRE, S, Peeters, Marc, VLIETINCK, R, PARKES, M, SATSANGI, J, JEWELL, D, ...

Oral budesonide for prevention of postsurgical recurrence in Crohn's disease. The IOIBD Budesonide Study Group (1999)

Cortot, A, Jewell, D, Leijonmarck, C E, Löfberg, R, Malchow, H, ...

BACKGROUND & AIMS: Prevention of postoperative recurrence after resection for Crohn's disease (CD) would be of great clinical benefit. The efficacy of oral budesonide for prevention of endoscopic...

Fine mapping a susceptibility locus on the X chromosome in the Belgian population in inflammatory bowel disease (IBD) (1999)

Vermeire, SAAR, Satsangi, J, Peeters, M, Parkes, M, Jewell, D, ...

Association of ulcerative colitis with rare VNTR alleles of the human intestinal mucin gene, MUC3 (1999)

Kyo, K, Parkes, M, Takei, Y, Nishimori, H, Vyas, P, Satsangi, J, ...

No evidence for linkage on chromosome 16-12-7 and 3 in the Belgian population may reflect genetic heterogeneity of inflammatory bowel disease (1998)

Peeters, M, Parkes, M, Satsangi, J, Jewell, D, ...

Genetics of inflammatory bowel disease: Contribution of the X chromosome (1998)

Satsangi, J, Parkes, M, Peeters, M, Vyas, P, Rutgeerts, Paul; U0007636, ...

Use of eluted peptide sequence data to identify the binding characteristics of peptides to the insulin-dependent diabetes susceptibility allele HLA-DQ8 (DQ 3.2) (1997)

Godkin, A, Friede, T, Davenport, M, Stevanovic, S, Willis, A, Jewell, D, ...

Budesonide prolongs time to relapse in ileal and ileocaecal Crohn's disease. A placebo controlled one year study (1996)

Malchow, H, Lamers, C, Danielsson, A, Olaison, G, ...

BACKGROUND AND AIMS: To evaluate the efficacy and safety of the topical corticosteroid budesonide, given in an oral controlled release formulation for maintenance of remission in patients with ileal...

I.O.I.B.D. Questionnaire on the clinical use of Azathioprine, 6-Mercaptopurine, Cyclosporine-A and Methotrexate in the treatment of I.B.D (1996)

Meuwissen, SGM, Ewe, K, Gassull, MA, Geboes, K, Jewell, D, Pallone, F, ...

A comparison of budesonide with prednisolone for active Crohn's disease (1994)

Löfberg, R, Malchow, H, Lamers, C, Olaison, G, Jewell, D, ...

BACKGROUND. Patients with active Crohn's disease are often treated with corticosteroids, but the treatment has many side effects. Budesonide is a potent, well-absorbed corticosteroid, but because of...

Reducing transfer times for coronary angiography in patients with acute coronary syndromes: one solution to a national problem

Bellenger, N G, Wells, T, Hitchcock, R, Watkins, M, Duffet, C, Jewell, D, ...